This Marijuana Stock Darling Crashed 17% in May

What happened Following comments from a competitor s CEO that suggest competition for the company s epilepsy drug is in the works shares in GW Pharmaceuticals NASDAQ GWPH 160 tumbled by 17 2 in May according to S amp P Global Market Intelligence So what